Invention Grant
US08663704B2 Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (LDL) per-oxidation in humans
有权
用于改善血脂特征的组合物和方法，并且任选地减少人体中氧化的低密度脂蛋白（LDL）
- Patent Title: Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (LDL) per-oxidation in humans
- Patent Title (中): 用于改善血脂特征的组合物和方法，并且任选地减少人体中氧化的低密度脂蛋白（LDL）
-
Application No.: US13093201Application Date: 2011-04-25
-
Publication No.: US08663704B2Publication Date: 2014-03-04
- Inventor: John A. Minatelli , W. Stephen Hill , Rudi E. Moerck
- Applicant: John A. Minatelli , W. Stephen Hill , Rudi E. Moerck
- Applicant Address: US FL Eustis
- Assignee: U.S. Nutraceuticals, LLC
- Current Assignee: U.S. Nutraceuticals, LLC
- Current Assignee Address: US FL Eustis
- Agency: Allen, Dyer, Doppelt, Milbrath & Gilchrist, P.A.
- Main IPC: A61K31/202
- IPC: A61K31/202 ; A61K31/05 ; A61K35/56
Abstract:
A composition and method which improves blood lipid profiles and optionally reduces low density lipoprotein (LDL) per-oxidation in humans by administering a therapeutic amount of a composition comprising krill oil in combination with astaxanthin or a mixture of fish oil derived, choline based, phospholipid bound omega-3 fatty acid mixture including phospholipid bound polyunsaturated EPA and DHA. In one embodiment, the krill oil is derived from Euphasia spp., comprising Eicosapentaenoic (EPA) and Docosahexaenoic (DHA) fatty acids in the form of triacylglycerides and phospholipids. The krill oil includes at least 10% EPA and 5% DHA, of which greater than 50% are in the form of phospholipids and the 1-4000 mg of krill oil per daily dose is delivered.
Public/Granted literature
Information query
IPC分类:
